Milestone Pharmaceuticals Inc. (MIST) Net Income by Year
Milestone Pharmaceuticals Inc. reported a net loss of $63K in fiscal year 2025. This represents a decrease of 51.9% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Milestone Pharmaceuticals Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MIST Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
MIST Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Milestone Pharmaceuticals Inc. financials
Frequently Asked Questions
What was Milestone Pharmaceuticals Inc.'s net income in fiscal year 2025?
Milestone Pharmaceuticals Inc. reported a net loss of $63K in fiscal year 2025.
How fast is Milestone Pharmaceuticals Inc.'s net income growing?
Milestone Pharmaceuticals Inc. (MIST) net income fell by 51.9% year over year, from -$42K to -$63K in fiscal year 2025.
How has Milestone Pharmaceuticals Inc.'s net income changed over the years?
Across the 8 fiscal years this page covers, Milestone Pharmaceuticals Inc. (MIST) net income went from -$23.2M in fiscal year 2018 to -$63K in fiscal year 2025.
What was Milestone Pharmaceuticals Inc.'s net income in the most recent quarter?
Milestone Pharmaceuticals Inc. (MIST) reported -$28.6M in net income in Q2 2026. This represents a decrease of 120.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Milestone Pharmaceuticals Inc. (MIST) reported on that line in every period on record.